Aspire Biopharma Holdings's total assets for Q4 2025 were $1.31M, a decrease of -45.40% from the previous quarter. ASBP total liabilities were $7.69M for the fiscal quarter, a -44.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.